NeuroPace annual operating expenses
2020
2021
2022
2023
2024
2025
NeuroPace Operating Expenses Growth & History (NPCE)
NeuroPace's operating expenses was $93.6M for fiscal 2025.
View full NeuroPace company overviewNeuroPace annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $93.6M | $12.8M | +15.85% |
| 2024 | 2024-12-31 | $80.8M | $5.5M | +7.25% |
| 2023 | 2023-12-31 | $75.3M | $2.0M | +2.74% |
| 2022 | 2022-12-31 | $73.3M | $16.1M | +28.19% |
| 2021 | 2021-12-31 | $57.2M | $13.8M | +31.97% |
| 2020 | 2020-12-31 | $43.3M | — | — |
NeuroPace quarterly operating expenses
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $24.0M | −$353,000 | −1.45% |
| Q1 2026 | 2026-03-31 | $23.6M | $1.1M | +5.01% |
| Q4 2025 | 2025-12-31 | $22.9M | $3.1M | +15.41% |
| Q3 2025 | 2025-09-30 | $23.8M | $4.1M | +20.88% |
| Q2 2025 | 2025-06-30 | $24.4M | $4.0M | +19.83% |
| Q1 2025 | 2025-03-31 | $22.5M | $1.6M | +7.66% |
| Q4 2024 | 2024-12-31 | $19.8M | $1.2M | +6.69% |
| Q3 2024 | 2024-09-30 | $19.7M | $1.5M | +8.14% |
| Q2 2024 | 2024-06-30 | $20.4M | $538,000 | +2.71% |
| Q1 2024 | 2024-03-31 | $20.9M | $2.2M | +11.75% |
| Q4 2023 | 2023-12-31 | $18.6M | −$66,000 | −0.35% |
| Q3 2023 | 2023-09-30 | $18.2M | $19,000 | +0.10% |
| Q2 2023 | 2023-06-30 | $19.8M | $1.4M | +7.52% |
| Q1 2023 | 2023-03-31 | $18.7M | $670,000 | +3.72% |
| Q4 2022 | 2022-12-31 | $18.7M | $1.6M | +9.19% |
| Q3 2022 | 2022-09-30 | $18.2M | $4.4M | +32.10% |
| Q2 2022 | 2022-06-30 | $18.4M | $4.5M | +32.05% |
| Q1 2022 | 2022-03-31 | $18.0M | $5.7M | +45.72% |
| Q4 2021 | 2021-12-31 | $17.1M | $5.9M | +52.60% |
| Q3 2021 | 2021-09-30 | $13.8M | $3.0M | +28.01% |
| Q2 2021 | 2021-06-30 | $14.0M | $5.1M | +57.48% |
| Q1 2021 | 2021-03-31 | $12.4M | −$148,000 | −1.18% |
| Q4 2020 | 2020-12-31 | $11.2M | — | — |
| Q3 2020 | 2020-09-30 | $10.7M | — | — |
| Q2 2020 | 2020-06-30 | $8.9M | — | — |
| Q1 2020 | 2020-03-31 | $12.5M | — | — |
NeuroPace operating expenses trends
Over the last five fiscal years, NeuroPace's operating expenses increased from $43.3M to $93.6M, a change of $50.2M. The latest reported quarter, Q2 2026, shows $24.0M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NeuroPace source filings ↗